Cargando…
Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321695/ https://www.ncbi.nlm.nih.gov/pubmed/34345873 http://dx.doi.org/10.1016/j.puhip.2021.100165 |
_version_ | 1783730906123468800 |
---|---|
author | Okereke, Melody |
author_facet | Okereke, Melody |
author_sort | Okereke, Melody |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8321695 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-83216952021-07-30 Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines? Okereke, Melody Public Health Pract (Oxf) Letter to the Editor Elsevier 2021-07-30 /pmc/articles/PMC8321695/ /pubmed/34345873 http://dx.doi.org/10.1016/j.puhip.2021.100165 Text en © 2021 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Letter to the Editor Okereke, Melody Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines? |
title | Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines? |
title_full | Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines? |
title_fullStr | Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines? |
title_full_unstemmed | Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines? |
title_short | Towards vaccine equity: Should big pharma waive intellectual property rights for COVID-19 vaccines? |
title_sort | towards vaccine equity: should big pharma waive intellectual property rights for covid-19 vaccines? |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321695/ https://www.ncbi.nlm.nih.gov/pubmed/34345873 http://dx.doi.org/10.1016/j.puhip.2021.100165 |
work_keys_str_mv | AT okerekemelody towardsvaccineequityshouldbigpharmawaiveintellectualpropertyrightsforcovid19vaccines |